Table 1: Demographic
characteristics.
|
|
Total N
= 50 |
No
rejection N = 40 |
Rejection N = 6 |
Other
graft disease1 N = 4 |
P
value |
|
Age
(years) Mean ± SD |
10.1 ± 5.6 |
9.3 ± 5.5 |
12.8 ± 6.0 |
14 ± 4.5 |
0.15 |
|
Race
N (%)2 Caucasian Hispanic African American Other |
9 (18) 18 (36) 15 (30) 8 (16) |
9 (100) 14 (77.8) 10 (66.7) 7 (87.5) |
0 1 (5.6) 4 (26.7) 1 (12.5) |
0 3 (16.7) 1 (6.7) 0 |
0.25 0.16 0.11 0.66 |
|
Gender
N (%) Male female |
32 (64) 18 (36) |
24 (75) 16 (88.8) |
5 (15.6) 1 (5.6) |
3 (9.4) 1 (5.6) |
0.48 |
|
Diagnosis
N (%) Congenital Acquired |
31 (77.5) 19 (22.5) |
28 (90.3) 12 (63.2) |
3 (9.7) 3 (15.8) |
0 4 (21) |
0.01* |
|
Donor
source N (%) LD DD |
11 (22) 39 (78) |
8 (72.7) 32 (82.1) |
1 (9.1) 5 (12.8) |
2 (18.2) 2 (5.1) |
0.36 |
|
Average
HLA mismatches N |
3.6 ± 1.5 |
3.4 ± 1.6 |
4.5 ± 0.6 |
4.3 ± 1.0 |
0.16 |
1Other
graft disease comprised of FSGS in three and drug induced interstitial
nephritis in one; 2Each race versus the other races; *Association
between primary diagnosis in group with no rejection versus other graft disease.